Fermectin 1% Solution for Injection for Pigs

Country: Ireland

Language: English

Source: HPRA (Health Products Regulatory Authority)

Active ingredient:

Ivermectin

Available from:

Chanelle Animal Health Ltd.

ATC code:

QP54AA01

INN (International Name):

Ivermectin

Dosage:

1 percent weight/volume

Pharmaceutical form:

Solution for injection

Prescription type:

LM: Licensed Merchant as defined in relevant national legislation

Therapeutic group:

Pigs

Therapeutic area:

ivermectin

Therapeutic indications:

Endectoparasiticides

Authorization status:

Authorised

Authorization date:

2001-06-20

Summary of Product characteristics

SUMMARY OF PRODUCT CHARACTERISTICS
1 NAME OF THE VETERINARY MEDICINAL PRODUCT
Fermectin 1% Solution for Injection for Pigs.
2 QUALITATIVE AND QUANTITATIVE COMPOSITION
ACTIVE SUBSTANCE: Ivermectin, 1.0% w/v
For a full list of excipients, see section 6.1.
3 PHARMACEUTICAL FORM
Solution for Injection.
A clear, colourless solution.
4 CLINICAL PARTICULARS
4.1 TARGET SPECIES
Pigs
The veterinary medicinal product can be given to all ages of animals
including piglets.
4.2 INDICATIONS FOR USE, SPECIFYING THE TARGET SPECIES
The veterinary medicinal product is indicated for the effective
treatment and control of the following harmful parasites
of pigs:
GASTROINTESTINAL WORMS (adult and fourth stage larvae):
_Ascaris suum,_
_Hyostrongylus rubidus_,
_Oesophagostomum spp_,
_Strongyloides ransomi_ (adult and somatic larval stage)
LUNGWORMS:
_Metastrongylus spp_. (adult)
LICE:
_Haematopinus suis_
MANGE MITES:
_Sarcoptes scabiei_ var._ suis_
4.3 CONTRAINDICATIONS
H
E
A
L
T
H
P
R
O
D
U
C
T
S
R
E
G
U
L
A
T
O
R
Y
A
U
T
H
O
R
I
T
Y
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
_D_
_a_
_t_
_e_
_ _
_P_
_r_
_i_
_n_
_t_
_e_
_d_
_ _
_2_
_3_
_/_
_1_
_2_
_/_
_2_
_0_
_1_
_5_
_C_
_R_
_N_
_ _
_7_
_0_
_2_
_2_
_4_
_8_
_9_
_p_
_a_
_g_
_e_
_ _
_n_
_u_
_m_
_b_
_e_
_r_
_:_
_ _
_1_
Do not administer by the intravenous or intramuscular route.
Do not use in cases of known hypersensitivity to the active
ingredient.
Do not use in cats and dogs as severe adverse reactions may occur.
4.4 SPECIAL WARNINGS FOR EACH TARGET SPECIES
None.
4.5 SPECIAL PRECAUTIONS FOR USE
SPECIAL PRECAUTIONS FOR USE IN ANIMALS
Parasite resistance to any particul